Aceclidine hydrochloride

Aceclidine hydrochloride is a parasympathomimetic agent mainly used to treat open-angle glaucoma, a condition characterized by increased intraocular pressure. It works by constricting the pupil of the eye, thus decreasing intraocular pressure and potentially reducing the risk of optic nerve damage and vision loss. While marketed in Europe, it has not been used clinically in the United States. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Glaucostat, Aceclidine HCl and 3-Acetoxyquinuclidine hydrochloride. Its PubChem CID is 170367.